Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Researchers assessed the impact of recombinant accessory protein-deficient severe acute respiratory syndrome coronavirus 2 immunization against SARS-CoV-2 transmission and disease severity.

Related Keywords

United States ,American , ,Coronavirus Disease Covid 19 ,Covid 19 ,Protein ,Cars ,Ars Cov 2 ,Ngiotensin ,Ngiotensin Converting Enzyme 2 ,Essay ,Coronavirus ,Efficacy ,Nzyme ,Frequency ,Immunization ,Kidney ,Lungs ,Embrane ,Prophylaxis ,Espiratory ,Serine ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,